Rivaroxaban Versus Warfarin for Thromboprophylaxis in Children With Giant Coronary Aneurysms After Kawasaki Disease
Conditions: Kawasaki Disease; Coronary Aneurysm; Rivaroxaban; Warfarin; Antithrombotic Drug Interventions: Drug: Rivaroxaban Oral Tablet or Suspension [Xarelto]; Drug: Aspirin or Clopidogrel; Drug: Warfarin Sponsor: Children's Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Condition: Antiphospholipid Syndrome Interventions: Drug: Telitacicept; Drug: Rituximab; Drug: Aspirin; Drug: Warfarin; Drug: Hydroxychloroquine; Drug: Prednisone Sponsor: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
Rivaroxaban Versus Warfarin for Thromboprophylaxis in Children With Giant Coronary Aneurysms After Kawasaki Disease
Conditions: Kawasaki Disease; Coronary Aneurysm; Rivaroxaban; Warfarin; Antithrombotic Drug Interventions: Drug: Rivaroxaban Oral Tablet or Suspension [Xarelto]; Drug: Aspirin or Clopidogrel; Drug: Warfarin Sponsor: Children's Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Condition: Antiphospholipid Syndrome Interventions: Drug: Telitacicept; Drug: Rituximab; Drug: Aspirin; Drug: Warfarin; Drug: Hydroxychloroquine; Drug: Prednisone Sponsor: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
Rivaroxaban Versus Warfarin for Thromboprophylaxis in Children With Giant Coronary Aneurysms After Kawasaki Disease
Conditions: Kawasaki Disease; Coronary Aneurysm; Rivaroxaban; Warfarin; Antithrombotic Drug Interventions: Drug: Rivaroxaban Oral Tablet or Suspension [Xarelto]; Drug: Aspirin or Clopidogrel; Drug: Warfarin Sponsor: Children's Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Condition: Antiphospholipid Syndrome Interventions: Drug: Telitacicept; Drug: Rituximab; Drug: Aspirin; Drug: Warfarin; Drug: Hydroxychloroquine; Drug: Prednisone Sponsor: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
Warfarin Dosage Adjustment Model Analysis Study
Condition: Warfarin Intervention: Behavioral: Warfarin dosage adjustment model Sponsors: Chinese University of Hong Kong; Professor Bryan Ping Yen YAN (byan) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2022 Category: Research Source Type: clinical trials
